Gilboa David Abraham 4
4 · Warby Parker Inc. · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
Warby Parker (WRBY) CEO Dave Gilboa Sells 54,347 Shares
What Happened
- Dave Gilboa, CEO of Warby Parker, exercised/converted derivative securities and sold 54,347 shares on July 6, 2026. He acquired shares via an option exercise/conversion at an exercise price of $3.83 per share (cost ≈ $208,149) and then sold those 54,347 shares in the open market at an average execution price of $29.84, generating gross proceeds of about $1,621,714. The filings show related zero-price conversion/settlement entries for derivative securities (conversion of Class B common stock/derivative steps).
Key Details
- Transaction date: July 6, 2026.
- Sale: 54,347 shares sold at an average price of $29.84 (prices ranged $29.75–$30.00); total proceeds ≈ $1,621,714. (F2)
- Exercise/Acquisition: 54,347 shares acquired via exercise/conversion at $3.83/share; cash paid ≈ $208,149. (F3)
- Derivative/conversion entries at $0 reflect conversion/settlement steps of derivative/Class B stock recorded in the filing. (F4, F5)
- The sale was executed under a pre-established Rule 10b5-1 trading plan adopted March 17, 2026. (F1)
- Shares owned after the reported transactions: not specified in the excerpt provided.
- Filing timeliness: no late-filing notation provided in the submitted excerpt.
Context
- This was an exercise-and-sell sequence: Gilboa exercised options/converted derivatives (incurring the exercise cost) and then sold the resulting shares in the open market. Such transactions are commonly used to monetize vested option holdings or satisfy tax/costs and, when done under a 10b5-1 plan, are prearranged trades rather than ad-hoc market-timing decisions.
- Footnotes clarify the option grant (granted Feb 22, 2017; fully vested; expires Feb 21, 2027) and the conversion mechanics for Class B common stock, which can convert into Class A shares under specified conditions.
Insider Transaction Report
Form 4
Gilboa David Abraham
DirectorCo-Chief Executive Officer
Transactions
- Conversion
Class A Common Stock
2026-07-06+54,347→ 85,459 total - Sale
Class A Common Stock
[F1][F2]2026-07-06$29.84/sh−54,347$1,621,714→ 31,112 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-07-06−54,347→ 539,191 totalExercise: $3.83→ Class B Common Stock (54,347 underlying) - Exercise/Conversion
Class B Common Stock
[F4][F5]2026-07-06$3.83/sh+54,347$208,149→ 4,609,751 total→ Class A Common Stock (54,347 underlying) - Conversion
Class B Common Stock
[F4][F5]2026-07-06−54,347→ 4,555,404 total→ Class A Common Stock (54,347 underlying)
Holdings
- 1,656,770(indirect: By Trust)
Class B Common Stock
[F4][F5]→ Class A Common Stock (1,656,770 underlying)
Footnotes (5)
- [F1]These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2026.
- [F2]The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $29.75 to $30.00 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F3]The Stock option was granted on February 22, 2017, is fully vested, and will expire on February 21, 2027.
- [F4]The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (i) transfer of Class B Common Stock to a person or entity that is not in the transferor's permitted ownership group, (ii) October 1, 2031, (iii) with respect to any Class B Common Stock held by any person or entity in Neil Blumenthal's permitted ownership group, (A) such time as Neil Blumenthal is removed or resigns from the board of directors, or otherwise ceases to serve as a director, (B) such time as Neil Blumenthal ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Neil Blumenthal,
- [F5]and (iv) with respect to any Class B common stock held by any person or entity in Dave Gilboa's permitted ownership group, (A) such time as Dave Gilboa is removed or resigns from the board of directors, or otherwise ceases to serve as a director, (B) such time as Dave Gilboa ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Dave Gilboa.
Signature
/s/ Chris Utecht, Attorney-in-Fact|2026-07-08